Literature DB >> 19597135

Seropositive myasthenia gravis: a nationwide epidemiologic study.

Anne Taraldsen Heldal1, Jone Furlund Owe, Nils Erik Gilhus, Fredrik Romi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19597135     DOI： 10.1212/WNL.0b013e3181ad53c2

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  19 in total

Review 1.  Myasthenia gravis - autoantibody characteristics and their implications for therapy.

Authors:  Nils Erik Gilhus; Geir Olve Skeie; Fredrik Romi; Konstantinos Lazaridis; Paraskevi Zisimopoulou; Socrates Tzartos
Journal:  Nat Rev Neurol       Date:  2016-04-22       Impact factor: 42.937

2.  Myasthenia gravis: a changing pattern of incidence.

Authors:  I Casetta; E Groppo; R De Gennaro; E Cesnik; L Piccolo; S Volpato; E Granieri
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

3.  CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.

Authors:  Yong Zhang; Xiuying Zhang; Yan Xia; Xiao Jia; Hao Li; Yanyan Zhang; Zhen Shao; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Chenghua Xiao; Deqin Geng; Yonghai Liu; Guiyun Cui; Ruiguo Dong; Xiaoyu Huang; Tingyan Yu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 4.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 5.  Epidemiology of thymoma and associated malignancies.

Authors:  Eric A Engels
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

6.  IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis.

Authors:  Yang Shumei; Li Yi; Meng Huanyu; Li Zhibin; Jin Wanlin; Xu Liqun; Yang Huan
Journal:  Eur J Clin Pharmacol       Date:  2019-02-07       Impact factor: 2.953

7.  TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis.

Authors:  Yong Zhang; Zhen Shao; Xiuying Zhang; Xiao Jia; Yan Xia; Yanyan Zhang; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Ruiguo Dong; Chenghua Xiao; Deqin Geng; Yonghai Liu
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-24       Impact factor: 4.147

8.  Tonifying spleen and replenishing kidney method of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis.

Authors:  Bibo Lu; Qing Ye; Yuting Pan; Jiachun Lu; Lu Li; Yuxuan Peng; Min He; Weiyin Chen; Xueping Yang
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

9.  Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development.

Authors:  Anne Taraldsen Heldal; Geir Egil Eide; Fredrik Romi; Jone Furlund Owe; Nils Erik Gilhus
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies.

Authors:  Andreas Totzeck; Petra Mummel; Oliver Kastrup; Tim Hagenacker
Journal:  Eur J Transl Myol       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.